Eyüpoğlu, N. D., O. E. Çınar, S. Aksu, Y. Büyükaşık, N. Sayınalp, H. Demiroğlu, H. Göker, O. İ. Özcebe, and İ. C. Haznedaroğlu. “Event-Free Survival in Patients With Chronic Myeloid Leukemia Receiving Front-Line Imatinib Mesylate”. Acta Medica, vol. 53, no. 3, June 2022, pp. 277-83, doi:10.32552/2022.ActaMedica.745.